Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
4,971,949
-
Total 13F shares
-
316,052
-
Share change
-
-358,732
-
Total reported value
-
$3,248,899
-
Price per share
-
$10.28
-
Number of holders
-
16
-
Value change
-
-$2,235,427
-
Number of buys
-
10
-
Number of sells
-
5
Institutional Holders of Tempest Therapeutics, Inc. - Common Stock (TPST) as of Q3 2025
As of 30 Sep 2025,
Tempest Therapeutics, Inc. - Common Stock (TPST) was held by
16 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
316,052 shares.
The largest 10 holders included
VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, BlackRock, Inc., FMR LLC, DRW Securities, LLC, UBS Group AG, Belvedere Trading LLC, MORGAN STANLEY, OSAIC HOLDINGS, INC., and CIBC Private Wealth Group LLC.
This page lists
16
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.